微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 8.47% | 164.69% | 161.42% | 37/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.24% | 28.06% | 186.73% | 59/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.13% | -7.38% | -30.25% | 90/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.62% | -71.63% | -49.38% | 93/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.2% | -41.39% | 26.48% | 91/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.53% | -41.03% | 107.38% | 75/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.22% | -58.22% | -78.63% | 82/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.71% | -51.94% | 4.58% | 70/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 5.46% | -40.46% | 27.27% | 62/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.29% | -26.42% | 46.92% | 57/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.92% | -14.62% | -75.42% | 40/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 11.88% | 56.73% | 29.55% | 35/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.17% | 20.66% | 57.29% | 41/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.83% | 31.6% | 70.47% | 43/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.42% | 82.89% | -54.88% | 34/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 7.58% | 165.96% | -0.26% | 72/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.6% | 63.44% | 71.56% | 52/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.43% | 54.36% | 136.9% | 62/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.87% | 8.09% | -34.39% | 51/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.85% | -43.45% | -38.71% | 104/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.65% | -32.02% | 62.02% | 71/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.87% | -53.78% | 65.9% | 75/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.73% | -72.01% | -65.67% | 62/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.04% | 67.44% | -26.32% | 88/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.84% | 263.83% | 10.14% | 49/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 6.21% | 400.81% | 0.49% | 29/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 6.18% | 1717.65% | 105.32% | 7/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.01% | -55.34% | 60.11% | 101/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.88% | -68.67% | 51.61% | 88/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.24% | -55.07% | 264.71% | 90/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.34% | -65.38% | -94.96% | 77/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 6.74% | 912.05% | 12.33% | 72/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6% | 108.26% | 117.39% | 47/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.76% | 365.38% | 181.06% | 58/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.98% | 323.69% | 218.31% | 58/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -0.83% | -125% | -128.81% | 96/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.88% | -36.4% | 377.02% | 57/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -1.04% | -131.42% | -136.9% | 77/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -0.44% | -130.57% | -113.22% | 68/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |